-
1 Comment
McKesson Corporation is currently in a long term uptrend where the price is trading 4.1% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
McKesson Corporation's total revenue rose by 5.8% to $63B since the same quarter in the previous year.
Its net income has dropped by 3447.3% to $-6B since the same quarter in the previous year.
Finally, its free cash flow grew by 482.2% to $1B since the same quarter in the previous year.
Based on the above factors, McKesson Corporation gets an overall score of 4/5.
Industry | Medical Distribution |
---|---|
Sector | Healthcare |
ISIN | US58155Q1031 |
CurrencyCode | USD |
Exchange | NYSE |
Dividend Yield | 0.6% |
---|---|
Target Price | 430.15 |
Beta | 0.59 |
Market Cap | 50B |
PE Ratio | 16.64 |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for MCK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024